Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Attwill Vascular Technologies
AddedFeb 17, 2024
UpdatedJun 18, 2026
Attwill Vascular Technologies

Attwill Vascular Technologies

Pre-Seed

ATTWILL Vascular, founded in 2013, innovates in vascular technology to enhance patient care and reduce catheter-related complications.

HQ
Lodi, WI, US
Founded
2013
Overview
Compare
Fundraising
Employees

Attwill Vascular Technologies, founded in 2013, aims to end catheter-related failures in vascular access and improve patient quality of life during catheter treatments. Leveraging expertise in vascular technology and material science, the company develops innovative accessory products that significantly reduce complications from vascular access devices.

Attwill Vascular Technologies has made notable advancements in the field, enhancing clinical outcomes and patient care. Their innovative products have been instrumental in reducing complications, thereby positively impacting the healthcare industry.

Attwill Vascular Technologies - Similar Companies

Access Vascular logo

Access Vascular

Bluegrass Vascular Technologies logo

Bluegrass Vascular Technologies

Traverse Vascular logo

Traverse Vascular

Advanced Catheter Therapies logo

Advanced Catheter Therapies

acatheter.com

Cross Vascular logo

Cross Vascular

Cagent Vascular logo

Cagent Vascular

cagentvascular.com

Vascular Imaging logo

Vascular Imaging

Vascular Therapies logo

Vascular Therapies

vasculartx.com

PolyVascular logo

PolyVascular

polyvascular.com

Hemova Medical logo

Hemova Medical

Euphrates Vascular logo

Euphrates Vascular

Voyager Biomedical logo

Voyager Biomedical

Amplitude Vascular Systems logo

Amplitude Vascular Systems

avspulse.com

Versago Vascular Access logo

Versago Vascular Access

Scientia Vascular logo

Scientia Vascular

Attwill Vascular Technologies - Quick Facts

Who are Attwill Vascular Technologies' competitors?

Companies similar to Attwill Vascular Technologies include Access Vascular, Bluegrass Vascular Technologies, Traverse Vascular and Advanced Catheter Therapies.

When was Attwill Vascular Technologies founded?

Attwill Vascular Technologies was founded in 2013.

Where is Attwill Vascular Technologies' headquarters located?

Attwill Vascular Technologies' headquarters is located in Lodi, WI, US.

When was Attwill Vascular Technologies' last funding round?

Attwill Vascular Technologies' most recent funding round was for $1.4M (USD) in April 2020.

How much has Attwill Vascular Technologies raised to-date?

As of Apr 22, 2020, Attwill Vascular Technologies has raised a total of $4.4M (USD).

How many employees does Attwill Vascular Technologies have?

Attwill Vascular Technologies has 30 employees as of Feb 4, 2024.

Attwill Vascular Technologies - Classification

Industry
  • Hardware
Ownership
  • Private
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Medical Devices
Tags
  • Healthcare
  • Healthtech
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
SIC
  • 5000Wholesale Trade-durable Goods
  • 5040Professional And Commercial Equipment And Supplies
  • 5047Medical, Dental, And Hospital Equipment And Supplies
Show 7 more industry codes
NAICS
  • 330000Manufacturing
  • 620000Health Care and Social Assistance
  • 623000Nursing and Residential Care Facilities
SIC
  • 3900Miscellaneous Manufacturing Industries
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified